Woodline Partners LP Fusion Pharmaceuticals Inc. Transaction History

Woodline Partners LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.48 - $9.65 $358,178 - $1.39 Million	144,427 Added 185.08%	222,462 $2.14 Million
Q3 2023 Nov 14, 2023	BUY	$2.37 - $4.63 $184,942 - $361,302	78,035 New	78,035 $202,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $7.86 $64,000 - $202,025	-25,703 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.53 - $8.57 $985,895 - $1.87 Million	-217,637 Reduced 89.44%	25,703 $200,000
Q4 2021 Feb 14, 2022	BUY	$4.17 - $7.78 $369,958 - $690,233	88,719 Added 57.38%	243,340 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$7.83 - $9.41 $187 - $225	24 Added 0.02%	154,621 $1.23 Million
Q2 2021 Aug 16, 2021	BUY	$7.97 - $10.66 $239,123 - $319,831	30,003 Added 24.08%	154,597 $1.25 Million
Q1 2021 May 17, 2021	BUY	$9.75 - $13.09 $699,728 - $939,430	71,767 Added 135.85%	124,594 $1.34 Million
Q4 2020 Feb 16, 2021	SELL	$11.5 - $13.73 $267,559 - $319,442	-23,266 Reduced 30.58%	52,827 $621,000
Q3 2020 Nov 16, 2020	SELL	$11.8 - $17.1 $518,102 - $750,809	-43,907 Reduced 36.59%	76,093 $915,000
Q2 2020 Aug 14, 2020	BUY	$17.0 - $17.78 $2.04 Million - $2.13 Million	120,000 New	120,000 $2.1 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.